4 results
Approved WMOPending
The HOPE-3 trial will evaluate the effects of lipid modification with rosuvastatin and of blood pressure lowering with candesartan/hydrochlorothiazide (HCT) and their combination in a wide range of middle aged people, who are at average risk for…
Not approvedWill not start
Determine the prolonged effect of a 12 week physical exercise program in congestive heart failure patients.
Approved WMOCompleted
To demonstrate that Nanocort is safe and effectively reduces the inflammatory signs and symptoms of active GO.
Approved WMOCompleted
The primary objective in the study is to explore the effect of three different amplitude settings (50%…